Latka logo

How Visiopharm CEO Michael Grunkin grew Visiopharm to $9M revenue with a 96 person team in 2024.

Provider of image analysis and stereology software. The company provides software for quantitative microscopy within the life science industry. Its software combines the strengths of image analysis and stereology into one software platform, which is designed to operate on a wide variety of microscopes and virtual slide microscopes.

Last updated

Visiopharm Revenue

In 2024, Visiopharm's revenue reached $9M. The company previously reported $7.1M in 2023. Since its launch in 2001, Visiopharm has shown consistent revenue growth.

Visiopharm Revenue GrowthReported revenue / ARR by year$0$2M$4M$6M$8M$10M2001200320052007200920112013201520172019202120232024$0$6M$9MSource: GetLatka.com
YearMilestone
2024Visiopharm Hit $9m revenue in October 2024
2023Visiopharm Hit $7.1m revenue in December 2023
2021Visiopharm Hit $6.5m revenue in April 2021
2001Launched with $0 revenue

Visiopharm Valuation, Funding Rounds

Visiopharm has not publicly disclosed its valuation. The company has raised $15.5M in total funding to date.

Visiopharm has raised $15.5M in total funding across 1 round, with its most recent round in 2018.

Visiopharm Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$4M$8M$12M$16M$20M20012003200520072009201120132015201720182001 cumulative: $0 • 2001 Founded: $02018 cumulative: $16M • 2001 Founded: $0 • 2018 Funding round: $16M$16M2001 Founded: $0 valuationSource: GetLatka.com
YearRoundAmountValuation% Sold
2018Funding round$15.5M--

Visiopharm Employees & Team Size

Visiopharm employs approximately 96 people as of 2026, down from 105 in 2023.

Visiopharm has 96 total employees in different roles and functions and 536 sales reps that carry a quota.

Visiopharm Team GrowthReported headcount over time02550751001252001200320052007200920112013201520172019202120232024009696Source: GetLatka.com
YearMilestone
2024Reached 96 employees (December 2024)
2024Reached 99 employees (October 2024)
2023Reached 105 employees (December 2023)
2022Reached 108 employees (December 2022)
2021Reached 115 employees (December 2021)
2021Reached 102 employees (April 2021)

Founder / CEO

Michael Grunkin

» Digital Pathology » Image Analysis and APPs » Computer Aided Diagnostics » Stereology » Cancer research & diagnostics » Stain Quality Control » Immunohistochemistry » Quantification of biomarkers » Slide scanning » Medical Devices » Regulatory approvals » Customized image analysis

Q&A

QuestionAnswer
What's your age?-
Favorite online tool?-
Favorite book?-
Favorite CEO?-
Advice for 20 year old self-

Customers

We do not have customer count information for Visiopharm yet.

Frequently Asked Questions about Visiopharm

What is Visiopharm's revenue?

Visiopharm generates $9M in revenue.

Who founded Visiopharm?

Visiopharm was founded by Michael Grunkin.

Who is the CEO of Visiopharm?

The CEO of Visiopharm is Michael Grunkin.

How much funding does Visiopharm have?

Visiopharm raised $15.5M.

How many employees does Visiopharm have?

Visiopharm has 96 employees.

Where is Visiopharm headquarters?

Visiopharm is headquartered in Hoersholm, Denmark.

Compare Visiopharm to the industry

Visiopharm operates across multiple industries. Browse revenue, funding, and growth data for Visiopharm in each sector below.

Source Attribution

Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.

Company data last updated .

Visiopharm Revenue 2024: $9M ARR, $15.5M Raised